BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRAF
,
G-protein-coupled receptor binding
,
Influenza
,
Prostate
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bromodomain protein
Summary
General Info
Curated Studies
Most Correlated Studies
CD4+ T cells in Th17-promoting conditions treated with bromodomain inhibitors
Bromodomain-dependent stage-specific male genome programming by Brdt
Multiple myeloma cells treated with BET-bromodomain inhibitor JQ1
Burkitt lymphoma RAJI cells treated with bromodomain and extraterminal motif inhibitor JQ1
Pancreatic ductal cancer cell lines treated with the BET bromodomain inhibitor CPI203
Explore Curated Studies Results
Literature
Most Relevant Literature
The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells.
BRD7 deficiency leads to the development of obesity and hyperglycemia.
4-Acyl Pyrroles as Dual BET-BRD7/9 Bromodomain Inhibitors Address BETi Insensitive Human Cancer Cell…
BRD7 plays an anti-inflammatory role during early acute inflammation by inhibiting activation of the…
Inactivation of BRD7 results in impaired cognitive behavior and reduced synaptic plasticity of the m…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Dose-Finding Study of MK-8628, a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (B…
Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination T…
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitor BMS-986158 in Pediatric Can…
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemacicl…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ